Medincell

About Medincell

Medincell is committed to creating better medicines for all by impacting global health through purposeful innovation. Their mission involves developing an innovative and diverse portfolio of breakthrough therapies using cutting-edge long-acting injectable technology to enhance treatment efficiency, accessibility, and the quality of life for patients worldwide. They collaborate with leading pharmaceutical entities and foundations to introduce groundbreaking therapeutic solutions.

Products & Services

UZEDY(r):A monthly and every 2 months subcutaneous risperidone treatment for schizophrenia.

mdc-TJK:An investigational once-monthly subcutaneous long-acting injection of olanzapine for schizophrenia, with a favorable safety profile. Currently in Clinical Phase 3, developed in partnership with Teva Pharmaceuticals.

mdc-CWM:A one-time intraarticular celecoxib injection for post-operative pain relief after Total Knee Replacement surgery, potentially active for up to three months. Currently in Clinical Phase 3, developed in collaboration with Arthritis Innovation Corporation (AIC).

BEPO(r) Technology:A proprietary technology platform used to develop long-acting injectable treatments.

Specialties

Long-acting injectable technology Schizophrenia treatment Post-operative pain relief Therapeutic care delivery Collaborative pharmaceutical innovation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 28000000 MR: - FA: €28M FAN: 28000000	D: 2026-07-15 FD: 2026-07-15	2 investors
2	RT: Grant T: - FT: Grant	A: 6000000 MR: - FA: up to US$ 6 million FAN: 6000000	D: 2024-04-08 FD: 2024-04-08	1 investors

Debt Latest

2026-07-15

$28.0M

2 investors (Pro only)

Grant 2024-04-08

$6.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Medincell Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised